Nab-paclitaxel versus paclitaxel for taxane acute pain syndrome in solid tumors: a systematic review and meta-analysis

Authors

H. Li
Lai Wei (ORCID: https://orcid.org/0000-0001-9254-343X)
Zhiyong Wang (ORCID: https://orcid.org/0000-0002-2105-1021)

Institutions

Beihua University (CN)
Breast Center (CH)

Publication Details

Journal: Frontiers in Oncology
Published: 2026-01-14
DOI: https://doi.org/10.3389/fonc.2025.1650191
Primary Topic: Cancer Treatment and Pharmacology
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Nab-paclitaxel versus paclitaxel for taxane acute pain syndrome in solid tumors: a systematic review and meta-analysis

H. Li, Lai Wei, Zhiyong Wang

Jan 14, 2026

Frontiers in Oncology

Cancer Treatment and Pharmacology

article

Nab-paclitaxel versus paclitaxel for taxane acute pain syndrome in solid tumors: a systematic review and meta-analysis

H. Li, Lai Wei, Zhiyong Wang

January 14, 2026article en

Abstract

No abstract available for this paper.

Frontiers in OncologyVol. 15

Beihua University (CN), Breast Center (CH)

Openalex Percentile: Top 88%

Cancer Treatment and Pharmacology

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nab-paclitaxel versus paclitaxel for taxane acute pain syndrome in solid tumors: a systematic review and meta-analysis — H. Li, Lai Wei, et al. · Frontiers in Oncology (2026) | TGRS Research Map | TGRS